Most meningiomas are slow-growing and noncancerous, making them the least dangerous type of brain tumor you can be diagnosed with. But “not cancerous” doesn’t mean “not serious.” A meningioma’s seriousness depends on its grade, its location, and whether it causes symptoms. The majority of people with a meningioma do well with treatment or even just monitoring, though long-term effects on thinking, energy, and quality of life are more common than many people expect.
Tumor Grade Is the Biggest Factor
Meningiomas grow from the membranes surrounding the brain and spinal cord. They’re the most commonly diagnosed intracranial tumor, making up roughly one-third of all primary brain and central nervous system tumors. Women develop them about twice as often as men, and most are diagnosed around age 65.
Doctors classify meningiomas into three grades. Grade 1 tumors are benign, slow-growing, and account for the large majority of cases. Grade 2 (atypical) meningiomas grow faster and are more likely to return after removal. Grade 3 (anaplastic) meningiomas are rare and considered malignant. Grade 3 is now also assigned when a tumor carries certain genetic mutations linked to aggressive behavior, regardless of how it looks under a microscope.
The grade directly predicts recurrence. About 20% to 30% of grade 2 meningiomas come back within 10 years, even after surgery. For grade 3 tumors, that figure jumps to 70% to 80%. Grade 1 meningiomas have the lowest recurrence rates by far, though they can still return, especially if the surgeon wasn’t able to remove the entire tumor.
Location Matters as Much as Grade
A small, benign meningioma sitting on the top surface of the brain is a very different situation from one nestled at the skull base near critical nerves and blood vessels. Convexity meningiomas, the ones on the brain’s outer surface, are relatively straightforward to access surgically. Skull base meningiomas are among the most challenging to treat because they wrap around cranial nerves that control vision, hearing, facial movement, and swallowing.
The symptoms a meningioma causes reflect where it sits. Common symptoms include headaches, seizures, blurred vision, weakness or numbness in the arms or legs, and loss of balance. A tumor near the olfactory groove can destroy your sense of smell and eventually affect vision. One near the ear can press on cranial nerves and cause hearing loss or a painful condition called trigeminal neuralgia. A meningioma inside the brain’s fluid-filled chambers can block the flow of cerebrospinal fluid, causing a dangerous buildup of pressure called hydrocephalus.
Many meningiomas, though, cause no symptoms at all. They’re found incidentally on brain scans done for unrelated reasons, like after a head injury or during a migraine workup.
Not Every Meningioma Needs Treatment
If your meningioma is small, asymptomatic, and not growing, your doctor will likely recommend a watch-and-wait approach with periodic MRI scans. The guiding principle is straightforward: treat tumors that are causing symptoms or showing growth, and monitor the ones that aren’t. Even asymptomatic meningiomas get treated if imaging shows steady growth that would eventually cause problems.
There’s no single size cutoff that automatically triggers treatment. The decision is based on the full picture: whether the tumor is growing on serial scans, whether it’s in a location where even modest growth could damage important structures, and your overall health and age. Some people are monitored for years, sometimes decades, without ever needing intervention.
What Treatment Looks Like
Surgery is the primary treatment when a meningioma needs to come out. The goal is to remove as much of the tumor as possible. For convexity tumors, complete removal is often achievable. For skull base tumors, surgeons may intentionally leave a small remnant behind rather than risk damaging a critical nerve.
Radiation therapy plays a supporting role. Current guidelines recommend radiation after surgery for grade 2 tumors that couldn’t be fully removed. For grade 3 meningiomas, radiation is typically part of the treatment plan regardless. Radiation can also be the primary treatment for tumors in locations where surgery would be too risky, or for patients who aren’t good surgical candidates.
Long-Term Effects Are Common
This is the part that catches many people off guard. Even when a meningioma is benign and successfully treated, the aftermath often includes lasting effects on daily life. A large UK study tracking 467 people with noncancerous meningiomas found significantly elevated rates of depression, anxiety, headaches, fatigue, hearing loss, limb weakness, and cognitive problems compared to the general population. The risk of cognitive issues was more than four times higher than expected.
These findings aren’t isolated. A Swedish study of 190 patients found that nearly half had impaired quality of life after a median follow-up of nine years, and 43% experienced measurable problems with thinking and memory. A Dutch study with over 11 years of follow-up found that 67% of patients still had at least one neurological symptom. An Australian study similarly reported decreased quality of life across multiple areas compared to healthy peers.
Some of these effects come from the tumor itself, which may have been compressing brain tissue for years before detection. Others result from surgery or radiation. Fatigue is one of the most frequently reported issues and can persist long after treatment ends, even when scans look clean.
The Overall Outlook
For the majority of people diagnosed with a meningioma, this is a manageable condition with a good prognosis. Grade 1 tumors, which make up most cases, grow slowly, respond well to surgery, and have low recurrence rates. Many small, incidental meningiomas never need treatment at all.
Grade 2 and grade 3 tumors are genuinely serious. They require more aggressive treatment, carry meaningful recurrence risk, and need long-term surveillance with regular imaging. Grade 3 meningiomas in particular behave like a cancer and demand treatment accordingly.
What’s worth keeping in mind, regardless of grade, is that the medical seriousness of a meningioma and its impact on your daily life aren’t always the same thing. A tumor that’s “benign” on paper can still leave you dealing with fatigue, memory difficulties, or anxiety for years. Understanding that gap helps you plan for recovery realistically and seek the right support.